Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Tables)

v3.4.0.3
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2016
Fair Value Disclosures [Abstract]  
Financial assets and liabilities carried at fair value

The following tables set forth the Company’s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as follows (in thousands):

 

 

 

Fair Value Measurements at March 31, 2016 Using

 

 

 

Quoted Prices in

Active Markets for

Identical Assets

 

 

Significant Other

Observable

Inputs

 

 

Significant

Unobservable

Inputs

 

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds (1)

 

$

43,110

 

 

$

 

 

$

 

 

$

43,110

 

Marketable securities

 

 

454

 

 

 

 

 

 

 

 

 

454

 

 

 

$

43,564

 

 

$

 

 

$

 

 

$

43,564

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent warrant liabilities

 

$

 

 

$

 

 

$

3,532

 

 

$

3,532

 

 

 

 

Fair Value Measurements at December 31, 2015 Using

 

 

 

Quoted Prices in

Active Markets for

Identical Assets

 

 

Significant Other

Observable

Inputs

 

 

Significant

Unobservable

Inputs

 

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds (1)

 

$

42,590

 

 

$

 

 

$

 

 

$

42,590

 

Marketable securities

 

 

496

 

 

 

 

 

 

 

 

 

496

 

Total

 

$

43,086

 

 

$

 

 

$

 

 

$

43,086

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent warrant liabilities

 

$

 

 

$

 

 

$

10,464

 

 

$

10,464

 

 

(1)

Included in cash and cash equivalents

Warrant liabilities fair value assumptions

The estimated fair value of the contingent warrant liabilities was estimated using the following range of assumptions at March 31, 2016, and December 31, 2015:

 

 

 

March 31,

2016

 

December 31,

2015

Expected volatility

 

115% - 186%

 

166% - 183%

Risk-free interest rate

 

0.50% - 0.60%

 

0.64% - 0.74%

Expected term

 

0.69 - 0.94

 

0.94 - 1.19

 

Summary of changes in estimated fair value of Level 3 financial liabilities

The following table provides a summary of changes in the estimated fair value of the Company’s Level 3 financial liabilities for the three months ended March 31, 2016 (in thousands):

 

Balance at December 31, 2015

 

$

10,464

 

Decrease in estimated fair value of contingent warrant liabilities upon revaluation

 

 

(6,932

)

Balance at March 31, 2016

 

$

3,532

 

 

Outstanding debt carrying amount and estimated fair value

The carrying amount and the estimated fair value of the Company’s outstanding interest-bearing obligations at March 31, 2016, and December 31, 2015, are as follows (in thousands):

 

 

 

March 31, 2016

 

 

December 31, 2015

 

 

 

Carrying Amount

 

 

Estimated Fair Value

 

 

Carrying Amount

 

 

Estimated Fair Value

 

Hercules term loan

 

$

19,849

 

 

$

21,231

 

 

$

19,653

 

 

$

21,231

 

Novartis note

 

 

13,683

 

 

 

13,450

 

 

 

13,683

 

 

 

13,394

 

Servier loan

 

 

12,719

 

 

 

12,626

 

 

 

15,331

 

 

 

15,185

 

Total

 

$

46,251

 

 

$

47,307

 

 

$

48,667

 

 

$

49,810